Neopterin and procalcitonin are suitable biomarkers for exclusion of severe <it>Plasmodium falciparum </it>disease at the initial clinical assessment of travellers with imported malaria
<p>Abstract</p> <p>Background</p> <p>Most clinicians in developed, non-malaria endemic countries have limited or no experience in making clinical assessments of malaria disease severity and subsequent decisions regarding the need for parenteral therapy or high-level mon...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-09-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/9/1/255 |